Source: RDARS Inc.
Market Herald logo


Be the first with the news that moves the market
  • RDARS Inc. (RDARS) has announced a non-brokered private placement for gross proceeds of US$1,000,000
  • The offering is fully subscribed to by an institutional investor
  • Charles Zwebner, CEO of RDARS, sat down with Sabrina Cuthbert to discuss the capital raise
  • RDARS is an early-stage autonomous robotics and drone technology company
  • RDARS Inc. (RDRS) opened trading at C$0.025

RDARS (RDARS) has announced a non-brokered private placement of units for gross proceeds of US$1,000,000.

Each unit will consist of one common share and one share purchase warrant. Each warrant shall entitle the holder to acquire an additional share at a price of US$0.06 for a period of 36 months.

The offering is fully subscribed to by an institutional investor.

The proceeds will be used for advancing the research and development of the company’s drone technology and general working capital purposes.

CEO Charles Zwebner commented on the capital raise.

“We are pleased that RDARS has begun to gain the attention of institutional investors. This first such financing demonstrates confidence in our breakout plans and reflects our belief that our shares are currently undervalued. We are so much looking forward to executing our business plans and projections for 2023, which is our momentum year.”

RDARS is advancing the security industry’s approach to protecting properties by introducing autonomous systems that allow for real-time response, situation awareness, verification, intervention, evidence recording, data capture, analysis, and immediate downstream transmissions to public safety agencies.

RDARS has the ability to receive, analyze, and downstream the data and inform public safety agencies who the perpetrators are before they even arrive at the property.

RDARS Inc. (RDRS) opened trading at C$0.025.

More From The Market Herald
Neuralink - Founder, Elon Musk.

" Neuralink brain chips approved for human trials

Elon Musk’s Neuralink, a brain implant firm, has received regulatory approval for U.S. human trials.

" @ the Bell: TSX snaps three-day losing skid

After a series of sessions in the red, Canada’s main stock index closed out Friday trading in the green as commodity prices nudged

" Marvell stock spikes 30 per cent on Q1 news  

Marvell Technology (NASDAQ:MRVL) shares rose more than 30 per cent Friday.